Although adipose tissue ROS and reliance on antioxidant activity are known to increase with both breast cancer and obesity [41], and lipid oxidative stress can be utilized to reduce obesity-associated fat accumulation [42], this study is the first to explore the specific interaction between GPX4 inhibition and obesity in breast cancer. The gene discussed is GPX4; the disease is obesity due to melanocortin 4 receptor deficiency.